Immunosuppressive drugs and fetal outcome

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 28, Issue 8, 2014, Pages 1174-1187

  Coscia, Lisa A ^a   Constantinescu, Serban ^b   Davison, John M ^c   Moritz, Michael J ^d,e   Armenti, Vincent T ^a  

^a UNIVERSITY OF CENTRAL FLORIDA   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d LEHIGH VALLEY HOSPITAL   (United States)

^e UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

fetus; immunosuppression; pregnancy; transplantation

Indexed keywords

AZATHIOPRINE; BELATACEPT; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ARTICLE; ATTENTION DEFICIT DISORDER; BIRTH DEFECT; CLUBFOOT; COGNITIVE DEVELOPMENT; FETUS DEVELOPMENT; FETUS OUTCOME; FOLLOW UP; GRAFT FAILURE; GRAFT RECIPIENT; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LONG TERM CARE; LOW BIRTH WEIGHT; MOTHER; NATIONAL TRANSPLANTATION PREGNANCY REGISTRY; ORGAN TRANSPLANTATION; PATIENT COUNSELING; PHYSICAL DEVELOPMENT; PLACENTA PREVIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROGENY; REGISTER; SAFETY; SPONTANEOUS ABORTION; TERATOGENICITY; TETRAPLOIDY; UNITED STATES; ABORTION, SPONTANEOUS; ADVERSE EFFECTS; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; FETUS; INCIDENCE; RISK FACTOR; TERATOGENESIS;

ABORTION, SPONTANEOUS; FEMALE; FETUS; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MYCOPHENOLIC ACID; ORGAN TRANSPLANTATION; PREGNANCY; RISK FACTORS; TERATOGENESIS; UNITED STATES;

EID: 84927166570     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2014.07.020     Document Type: Article

References (66)

1. J.E. Murray, D.E. Reid, and J.H. Harrison Successful pregnancies after human renal transplantation N Engl J Med 269 1963 341 433
2. J.M. Davison Pregnancy in renal allograft recipients: problems, prognosis and practicalities Bailliere's Clin Obstet Gynaecol 8 2 1994 501 525
3. National Transplantation Pregnancy Registry (NTPR) 2013 Annual report: gift of life institute Philadelphia, PA 2014
4. M.L. Wyld, P.A. Clayton, and S. Jesudason Pregnancy outcomes for kidney transplant recipients Am J Transplant 13 12 2013 3173 3182
5. N. Sibanda, J.D. Briggs, and J.M. Davison Pregnancy after organ transplantation: a report from the UK transplant pregnancy registry Transplantation 83 10 2007 1301 1307
6. B. Källén, M. Westgren, and A. Aberg Pregnancy outcome after maternal organ transplantation in Sweden BJOG 112 7 2005 904 909
7. The Mycophenolate Mofetil Renal Refractory Rejection Study Group Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection Transplantation 61 1996 722 729 (old 3)
8. E.M. Vasquez Sirolimus: a new agent for the prevention of renal allograft rejection Am J Health Syst Pharm 57 7 2000 437 451
9. J.M. Morales, A. Andres, and M. Rengel Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation Nephrol Dialy Trans 16 Suppl. 1 2001 121 124
10. SRTR Annual Report-Kidney [Internet]. [cited 2014 Feb 24]. Available from http://srtr.transplant.hrsa.gov/annual-reports/2011/default.aspx. [accessed 24.02.14].
11. Department of Health and Human Services Food and Drug labeling [Internet] [updated 2013 Jun 1; cited 2013 Oct 13]. Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=201.57 2013
12. H.C. Sachs Committee on Drugs, The transfer of drugs and therapeutics into human breast milk: an update on selected topics [cited 2013 Oct 16] Pediatrics [Internet] 132 3 2013 Aug 26 e796 e809 10.1542/peds.2013-1985 Available from: http://pediatrics.aappublications.org/content/132/3/e796.long/
13. Update on Overall Prevalence of Major Birth Defects - Atlanta Georgia, 1978 - 2005 [Internet] 2008 [Updated 2008 Jan 10; cited 2013 Oct 16. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5701a2.htm
14. J.G. Wilson Current status of teratology: General principles and mechanisms derived from animal studies Handbook of teratology 1 1977 Plenum Press New York, NY 47 57
15. F.C. Fraser, and A. Sajoo Teratogenic potential of corticosteroids in humans Teratology 51 1995 45 46
16. L. Park-Wyllie, P. Mazzotta, and A. Pastuszak Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies Teratology 62 6 2000 385 392
17. D. Oren, I. Nulman, and M. Makhija Using corticosteroids during pregnancy: are topical, inhaled, or systemic agents associated with risk? Canadian Fam Physician 50 2004 1083 1085
18. A. Hviid, and D. Mølgaard-Nielson Corticosteroid use during pregnancy and risk of orofacial clefts CMAJ 183 7 2011 796 804
19. J.D. Yeast Immunosuppressives in pregnant transplant patients-what risks? Pharmacology 30 1987 117 124
20. G.G. Briggs, R.K. Freeman, and S.J. Yaffee Azathioprine G.G. Briggs, R.K. Freeman, S.J. Yaffee, Drugs in Pregnancy and Lactation 8th ed. 2008 Wolters Kluwer Health Philadelphia 153 155
21. J.M. Friedman, and J.E. Polifka The effects of drugs on the fetus and nursing infant: a handbook for health care professionals 1996 John Hopkins University Press Baltimore
22. J. Rudolph, R.T. Schweizer, and S.A. Bartus Pregnancy in renal transplant patients Transplantation 27 1979 26 29
23. J.M. Davison Dialysis, transplantation, and pregnancy Am J Kidney Dis 17 1991 127 132
24. V.T. Armenti, K.M. Ahlswede, and B.A. Ahlswede National transplantation pregnancy registry - outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients Transplantation 57 1994 502 506
25. B.J. Cleary, and B. Kallen Early pregnancy azathioprine use and pregnancy outcomes Birth Defects Research (Part A): Clinical and Molecular Teratology 85 2009 647 654
26. S. Gabardi, S.A. Baroletti, and L.M. McDevitt Pharmaceutical Care A clinicians guide to donation and transplantation 2006 Applied Measurement Professional Inc Lenexa, KS 613 650
27. R.J. Mason, A.W. Thomson, and P.H. Whiting Cyclosporine-induced feto-toxicity in the rat Transplantation 39 1985 9 12
28. A. Fein, M. Vechoropoulos, and L. Nebel Cyclosporin-induced embryotoxicity in mice Biol Neonate 56 1989 165 173
29. M.D. Pickrell, R. Sawers, and J. Michael Pregnancy after renal transplantation: severe intra-uterine growth retardation during treatment with cyclosporin A BM J 296 1988 825
30. K. Paziana, M. Del Monaco, and E. Cardonick Ciclosporin use during pregnancy Drug Safety 36 5 2013 279 294
31. G.G. Briggs, R.K. Freeman, and S.J. Yaffee Cyclosporine G.G. Briggs, R.K. Freeman, S.J. Yaffee, Drugs in pregnancy and lactation 8th ed. 2008 Wolters Kluwer Health Philadelphia 450 453
32. B.B. Oz, R. Hackman, and T. Einarson Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis Transplantation 71 8 2001 1051 1055
33. V.T. Armenti, J.S. Radomski, and M.J. Moritz Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation J.M. Cecka, P.I. Terasaki, Clinical transplants 2001 2002 Terasaki Foundation Laboratory Los Angeles 97 105
34. D.E. Farley, J. Shelby, D. Alexander, and J.R. Scott The effect of two new immunosuppressive agents FK506 and Didemnin B, in murine pregnancy Transplantation 52 1991 106 110
35. A. Kainz, I. Harabacz, and I.S. Cowlrick Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus Transplantation 70 12 2000 1718 1721
36. N.M. Sifontis, L.A. Coscia, and M. Schiraldi Structural birth defects in the newborn of solid organ transplant recipients Am J Transplant S2 2008 1693A
37. H.W. Sollinger, S. Cho, and G. Danovitch Mycophenolate mofetil for the prevention of acute rejection in primary cadaver renal allograft recipients Transplantation 60 1995 225 232
38. Mycophenolate mofetil package insert 2013 Genentech USA Inc South San Francisco, CA
39. Mycophenolic acid package insert 2013 Novartis Pharmaceuticals East Hanover, NJ
40. N.M. Sifontis, L.A. Coscia, and S. Constantinescu Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus Transplantation 82 2006 1698 1702
41. S.M. Termini, M.J. Clary, and L.A. Coscia Parenthood with exposure to mycophenolic acid products Birth Defects Research (Part A) 94 5 2012 335
42. A. Jones, M.J. Clary, and E. McDermott Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products Prog Transplant 23 2 2013 153 157
43. fizer Philadelphia, PA, P Sirolimus package insert 2012
44. I. Jankowska, U. Oldakowska-Jednyak, and Z. Jabiry-Zieniewicz Absence of teratogenicity of sirolimus used during early pregnancy Transplant Proc 36 2004 3232 3233
45. M. Framarino dei Malatesta, L.E. Corona, and L. De Luca Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation Transplantation 15 91(9) 2011 e69
46. S. Constantinescu, L.A. Coscia, and M.J. Moritz Pregnancy Outcomes in Solid Organ Transplant Recipients with Exposure to Sirolimus Am J Transplant 13 5 2013 161
47. F. Keller, S. Wiesner, and D. Bunjes Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation Ann Transplant 17 4 2012 52 58
48. Everolimus package insert 2013 Novartis Pharmaceuticals East Hanover, NJ
49. M. Veroux, D. Corona, and P. Veroux Pregnancy under everolimus-based immunosuppression Transpl Int 24 12 2011 e115
50. P. Carta, L. Caroti, and M. Zanazzi Pregnancy in a kidney transplant patient treated with everolimus Am J Kidney Dis 60 2 2012 329
51. U. Heeman, and O. Viklicky The role of belatacept in transplantation: results and implications of clinical trials in the context of other new biological immunosuppressant agents Clin Transplant 27 1 2013 E3 11
52. D. Wojciechowski, and F. Vincenti Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update Biologics: Target and Therapy 6 2012 385 393
53. Belatacept package insert 2013 ristol-Myers Squibb Company Princeton, NJ, B
54. V.T. Armenti, M.J. Moritz, and E.H. Cardonick Immunosuppression in pregnancy. Choices for infant and maternal health Drugs 62 16 2002 2361 2375
55. Basiliximab package insert 2005 Novartis Pharmaceuticals East Hanover, NJ
56. Alemtuzumab package insert 2009 enzyme Corporation Cambridge, MA, G
57. J.A. Board, H.M. Lee, and D.A. Draper Pregnancy following kidney homotransplantation from a non-twin. Report of a case with concurrent administration of azathioprine and prednisone Obstet & Gynecol 29 3 1967 318 323
58. G. Rizzoni, J.H.H. Ehrich, and M. Broyer Successful pregnancies in woman on renal replacement therapy: report from the EDTA registry Nephrol Dial Transplant 7 1992 279 287
59. N.M. Sifontis, L.A. Coscia, and M.P. Lundgren Pregnancy outcomes in solid organ transplant recipients with a switch from a mycophenolic acid product to azathioprine prior to conception Am J Transplant 13 5 2013 161
60. National Transplantation Pregnancy Registry (NTPR) 2011 Annual report 2012 gift of life institute Philadelphia, PA
61. S. Constantinescu, P. Axelrod, and L. Coscia Pregnancy outcomes in kidney recipients who discontinued mycophenolic acid products prior to conception J Am Soc Nephrol 24S 2013 861A
62. C.W. Stanley, R. Gottlieb, and R. Zager Developmental well-being in offspring of women receiving cyclosporine post-renal transplant Transplant Proc 31 1999 241 242
63. V.T. Armenti, S. Constantinescu, and M.J. Moritz Pregnancy after transplantation Transplantation Reviews 22 2008 223 240
64. I. Nulman, M. Sgro, and M. Barrera Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant Pediatr Drugs 12 2 2010 113 122
65. B. Kociszewska-Najman, B. Pietrzak, and J. Moneta-Wielgos Study of the ophthalmic system of babies delivered to transplant recipients Transplantation 27;95 6 2013 847 851
66. B. Kociszewska-Najman, B. Pietrzak, and J. Schreiber-Zamora Ultrasonography of the brain, abdomen, and heart in neonates born to liver or renal transplant recipient mothers Ann Transplant 17 4 2012 Dec 31 113 119